EPO and neoplasm: These findings, coupled with our data describing that blocking endogenous EPO impaired macrophage re-programming (Figures 1C, D), promoted us to conceive that SAL might serve as an optimal alternative therapy acting by inducing endogenous EPO without the risk of stimulating tumor growth or promoting thrombosis.